PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.440
0.00 (0.00%)
At close: Apr 27, 2026, 4:00 PM EDT
1.440
0.00 (0.00%)
After-hours: Apr 27, 2026, 4:10 PM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $76.79 million as of April 27, 2026. Its market cap has increased by 69.97% in one year.
Market Cap
76.79M
Enterprise Value
-35.31M
1-Year Change
69.97%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $76.79M, a decrease of -95.24%. That is a compound annual growth rate of -42.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 76.79M | 15.46% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeonaBio | 80.78M |
| Edesa Biotech | 80.42M |
| TScan Therapeutics | 79.33M |
| Pelthos Therapeutics | 79.01M |
| aTyr Pharma | 78.26M |
| Filana Therapeutics | 77.05M |
| Pliant Therapeutics | 76.77M |
| MAIA Biotechnology | 76.14M |